The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

An important step is getting pneumococcal vaccination if it's recommended for you. This vaccine helps protect against pneumococcal disease, including, pneumococcal pneumonia, bloodstream infection ...

Merck & Co – known as MSD outside the US and Canada – has announced that its adult-specific 21-valent pneumococcal conjugate vaccine has been approved by the European Commission (EC). The vaccine, ...

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults “Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are ...

the wholly-owned subsidiary of Pharmaniaga Bhd, has entered into a research collaboration agreement with BioNet-Asia Co Ltd, a Thai-French biotech vaccine company, for the development of a ...

Amid the growing importance of pneumococcal vaccination to prevent pneumonia during the change of seasons, confusion is ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has reported positive trial results in children that will ramp up the pressure on Pfizer and ...

Frequently reported local and systemic reactions were generally mild to moderate, resolving within several days of vaccination, with no meaningful differences observed across the cohorts.